Press Secretary Karoline Leavitt announced during a media briefing at the White House that President Trump has signed 17 letters to the CEOs of pharmaceutical companies, including one that is being sent to Eli Lilly (LLY). The letters call on the companies to take action to lower prices for Americans. The letters call on the drugmakers to take action within the next 60 days with the intent to lower drug prices, Leavitt noted. Other publicly traded large-cap drugmakers include AstraZeneca (AZN), Bristol Myers (BMY), GSK (GSK), Johnson & Johnson (JNJ), Merck (MRK), Novartis (NVS), Pfizer (PFE), Roche (RHHBY) and Sanofi (SNY).
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Johnson & Johnson expands FDA filing for tremfya label in psoriatic arthritis
- Johnson & Johnson launches AI-powered Virtuguide System
- Trump administration mulls charging patent holders 1%-5% fee, WSJ reports
- How Johnson & Johnson Stock (JNJ) Discovered a New Lease on Life
- Pacira upgraded to Buy from Hold at Truist